US Executive Compensation Proxy SEC Filings — November 02, 2026

Executive Compensation Insights

By Gunpowder Editorial ·

10 high priority 10 total filings analysed

Executive Summary

The 2026-11-02 proxy batch is dominated by capital-structure repair and control events rather than operating performance: 4 of 10 filings seek reverse splits or share-class consolidations (Blaize, Curis, Digi Power X, plus Splash's dilutive issuance), 3 involve contested or special governance votes (Phunware proxy fight, Planet 13 merger, CPG Vintage adviser change), and 3 are routine director/auditor ratifications (C1 Fund, Cantor Fitzgerald Income Trust, Intelligent Bio Solutions).

The most material event is Planet 13's all-stock sale to Vireo Growth at a fixed 0.015383618 exchange ratio with full RSU acceleration and executive employment letters, a structure that aligns insiders with deal completion rather than standalone value. Splash Beverage's request for up to 32.7 million shares (Series D + note + expanded $135M ELOC) explicitly warns of 'significant dilution,' signaling acute liquidity stress and a pivot to health sciences via the CannEpil license. Across the batch, no filing disclosed period-over-period revenue or margin data, so the actionable intelligence is governance- and structure-driven: quorum thresholds, equity-plan share caps, exchange-cap compliance, and fee-rate changes. Insider activity was not disclosed in any enriched filing, a notable absence given the number of dilutive and control transactions. The common thread is balance-sheet and listing-rule pressure in small/micro-cap issuers, with shareholder votes in December 2026 serving as binary catalysts.

Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →

Filing types in this digest: DEF 14A · DEFM14A

Tracking the trend? Catch up on the prior US Executive Compensation Proxy SEC Filings digest from October 30, 2026.

Investment Signals (12)

  • Planet 13 Holdings (DEFM14A)
    ▲

    All-stock merger into Vireo Growth at 0.015383618 exchange ratio; board and independent special committee unanimously recommend FOR, backed by ATB Cormark fairness opinion; all RSUs vest in full immediately prior to effective time and are settled in merger consideration, with no RSUs assumed by Vireo [BULLISH for deal completion]

  • Planet 13 Holdings (DEFM14A) (BULLISH)
    ▲

    Named executives Larry Scheffler, Robert Groesbeck and Christopher Wren have employment offer letters with Vireo, and directors/officers hold interests beyond stockholders generally including accelerated RSU vesting — insider alignment with closing reduces deal-break risk

  • Digi Power X (DEF 14A) (BULLISH)
    ▲

    Board recommends FOR ALL five director nominees and FOR Proposals 2-6, including share-class consolidation and RSU/Option plan caps fixed at 10,139,668 shares each (~10% of 101,396,689 shares outstanding) with evergreen provisions — a governance simplification that could improve index/institutional eligibility

  • CPG Vintage Access Fund VII (DEF 14A) (BULLISH)
    ▲

    Proposed iCapital Fund Advisors advisory agreement reduces the contractual management fee rate from 0.30% to 0.25% after each fund's eighth Final Closing anniversary; Board unanimously recommends FOR — modest but permanent fee relief for unitholders

  • C1 Fund (DEF 14A) (NEUTRAL-BULLISH)
    ▲

    Board unanimously recommends FOR both Class I director nominees (terms to 2029) and FOR CBIZ CPAs as FY2026 auditor; routine, low-friction governance with 6,096,148 shares outstanding

  • Cantor Fitzgerald Income Trust (DEF 14A) (NEUTRAL)
    ▲

    Board recommends FOR all five director nominees and FOR Ernst & Young as FY2026 auditor; only ~$27,000 in proxy solicitation fees to Alliance Advisors — low-cost, routine meeting

  • Intelligent Bio Solutions (DEF 14A) (MIXED)
    ▲

    Board seeks approval of amended and restated 2019 Long Term Incentive Plan and issuance of up to 2,036,659 shares upon Series N-2 Warrant exercise under Nasdaq Rule 5635(d); say-on-pay and say-on-frequency votes included — equity-plan refresh supports retention but adds dilution

  • Phunware (DEF 14A) (MIXED)
    ▲

    Management (WHITE card) urges stockholders to discard activist Goldenwise Capital's gold card and vote FOR nominee Elliot Han; contested election creates event-driven volatility around the December 17 meeting

  • Splash Beverage Group (DEF 14A) (BEARISH)
    ▲

    Series D conversion price $1.00 with $0.15 floor; note conversion at lower of $1.75 or $0.01 above closing price; conversion cannot begin until later of December 31, 2026, NYSE American approval and stockholder approval — timing gate limits near-term dilution but confirms capital need

  • Splash Beverage Group (DEF 14A) (BEARISH)
    ▲

    ELOC expanded from $35 million to $100 million (total $135 million including prior amounts) with C/M Capital Partners; company warns approval creates 'significant dilution' but failure to approve would prevent issuance above the 19.99% Exchange Cap and likely force repeated special meetings

  • Blaize Holdings (DEF 14A) (BEARISH)
    ▲

    Reverse stock split proposed at 1-for-10 to 1-for-35 range alongside re-election of all seven directors including new nominee Dr. Kurt Lauk (age 80, appointed August 13, 2026 replacing Dr. Juergen Hambrecht) — split signals exchange minimum-bid compliance pressure

  • Curis (DEF 14A) (BEARISH)
    ▲

    Reverse split proposed at 1-for-5 to 1-for-12 with only 6,679,229 shares outstanding as of October 26, 2026 record date; Board retains authority to abandon — very small share count underscores listing-rule pressure

Risk Flags (10)

  • ▼

    Company explicitly warns stockholder approval of Series D and note share issuance will create 'significant dilution' to current stockholders; up to 12,683,908 shares underlying Series D plus $576,271 note, on top of up to 20,000,000 ELOC shares — potential dilution exceeds current share base

  • ▼

    Failure to approve would leave the company unable to issue shares above the 19.99% Exchange Cap, likely prevent conventional financing, and force repeated special meetings — a binary vote with financing-viability consequences

  • Blaize Holdings↓ [HIGH RISK]
    ▼

    Reverse split ratio of 1-for-10 to 1-for-35 is a classic remedy for exchange minimum bid price deficiency; no financial results disclosed in the proxy, leaving operating visibility limited

  • Curis↓ [HIGH RISK]
    ▼

    Reverse split at 1-for-5 to 1-for-12 with only 6,679,229 shares outstanding as of the October 26 record date — micro-cap share count and split proposal signal persistent listing-compliance and capital-access strain

  • Phunware↓ [MEDIUM-HIGH RISK]
    ▼

    Contested annual meeting with activist Richard Ding of Goldenwise Capital nominating an opposing Class II director against Board nominee Elliot Han; dueling WHITE and gold proxy cards create governance uncertainty and potential board turnover

  • Planet 13 Holdings↓ [MEDIUM RISK]
    ▼

    Directors and officers have interests in the merger beyond those of stockholders generally, including accelerated RSU vesting and employment offer letters with Vireo for Scheffler, Groesbeck and Wren — potential conflict in recommendation

  • Digi Power X↓ [MEDIUM RISK]
    ▼

    Proposal to raise quorum from 5% to 33⅓% could make it harder to conduct business if turnout is low; share-class consolidation and evergreen equity plans at ~10% each add structural dilution

  • ▼

    Series N-2 Warrant exercise of up to 2,036,659 shares under Nasdaq Rule 5635(d) plus amended 2019 LTIP approval — layered dilution without disclosed operating performance

  • ▼

    Adviser change from Macquarie Wealth Advisers to iCapital Fund Advisors following October 15, 2026 asset purchase agreement; fee cut only applies after eighth Final Closing anniversary, so near-term economics unchanged; subject to majority unitholder approval under 1940 Act

  • Batch-wide [INFORMATION RISK]
    ▼

    No filing disclosed period-over-period revenue, margin, or insider transaction data — investors lack fundamental confirmation to offset the governance and dilution headlines

Opportunities (10)

  • Fixed exchange ratio of 0.015383618 Vireo subordinate voting shares per Planet 13 share with unanimous board and special committee support plus fairness opinion; deal terms dated July 26, 2026 — spread capture opportunity if market price diverges from implied merger consideration

  • Phunware Proxy Fight (OPPORTUNITY)
    ◆

    Contested December 17, 2026 annual meeting with activist Goldenwise Capital seeking a board seat; event-driven volatility around WHITE vs gold card solicitation may create entry points depending on outcome

  • ◆

    Fee reduction from 0.30% to 0.25% after eighth Final Closing anniversary, Board unanimously recommends FOR, special meeting December 16, 2026 — modest NAV accretion for long-term unitholders

  • Digi Power X↓ (OPPORTUNITY)
    ◆

    Share-class consolidation into a single common class plus fixed plan caps at ~10% each could simplify capital structure and improve liquidity/index eligibility; AGM December 21, 2026

  • C1 Fund↓ (WATCH)
    ◆

    First annual meeting December 1, 2026 with clean governance slate and CBIZ auditor ratification; low materiality but a milestone for a newly public vehicle

  • Routine re-election of five nominees including Brandon Lutnick (Chairman since March 2025) and Kyle Lutnick (director since January 2026); E&Y ratification — stable governance with low solicitation cost (~$27,000)

  • Amended 2019 LTIP and warrant-share approval could unlock retention and financing flexibility; annual meeting December 3, 2026 — watch for say-on-pay dissent as a governance signal

  • Splash Beverage Group↓ (SPECULATIVE)
    ◆

    If Series D and ELOC approvals pass, the $135 million total ELOC capacity and CannEpil license pivot to Endovia Health Sciences could fund a strategic reset; conversion gated until at least December 31, 2026 limits immediate overhang

  • Blaize Holdings↓ (SPECULATIVE)
    ◆

    Reverse split, if executed at the low end (1-for-10), could restore bid-price compliance with less mechanical distortion; board re-election with new nominee Dr. Kurt Lauk adds independent-director continuity

  • Curis↓ (SPECULATIVE)
    ◆

    Board retains authority to abandon reverse-split amendments, providing optionality if share price recovers before the November 18, 2026 special meeting

Sector Themes (6)

  • Micro-Cap Capital-Structure Repair
    ◆

    4 of 10 filings (Blaize, Curis, Digi Power X, Splash) involve reverse splits, share-class consolidations, or dilutive issuance to address listing-rule or financing constraints — a cluster indicating broad stress among small issuers reliant on equity access

  • Contested Governance on the Rise
    ◆

    Phunware's activist proxy fight (Goldenwise Capital) and Planet 13's conflicted-interest disclosure (accelerated RSUs plus employment letters) show increased shareholder scrutiny of board recommendations and insider alignment in 2026

  • Equity-Plan and Dilution Creep
    ◆

    Digi Power X seeks fixed caps of 10,139,668 shares each for RSU and Option plans (~10% of shares outstanding) with evergreen provisions; Intelligent Bio Solutions seeks warrant-share approval and LTIP amendment; Splash seeks up to 32.7 million shares — dilution requests dominate the batch

  • Adviser and Fee Restructuring in Closed-End/Interval Funds
    ◆

    CPG Vintage Access Fund VII's shift from Macquarie to iCapital with a post-eighth-anniversary fee cut from 0.30% to 0.25% reflects ongoing consolidation and fee pressure in the '40 Act fund complex

  • Routine Governance Dominates Volume
    ◆

    C1 Fund, Cantor Fitzgerald Income Trust and Intelligent Bio Solutions are largely director/auditor ratifications with no financial disclosures — proxy-season volume is running ahead of substantive operating updates

  • Absence of Insider and Performance Data
    ◆

    None of the 10 enriched filings disclosed insider transactions or period-over-period financial comparisons, limiting fundamental signal extraction and shifting investor focus to structural and voting outcomes

Watch List (8)

  • Contested annual meeting December 17, 2026 at 11:00 a.m. ET; record date October 19, 2026; virtual registration deadline December 16 — watch WHITE vs gold card solicitation results and any settlement talks

  • Stockholder vote on Vireo merger (agreement dated July 26, 2026); watch for meeting date announcement and any competing bids given fairness opinion from ATB Cormark

  • Special meeting for Series D/note and ELOC approvals; conversion gated until later of December 31, 2026, NYSE American approval and stockholder approval — watch for NYSE American listing decision and financing milestones

  • Annual Meeting December 1, 2026; reverse split ratio (1-for-10 to 1-for-35) to be set by Board — watch exchange bid-price compliance timeline and any subsequent capital raise

  • 👁

    Special Meeting November 18, 2026 at 11:00 a.m. ET; record date October 26, 2026 — watch Board decision on split ratio and whether amendments are abandoned

  • AGM December 21, 2026 at 10:00 a.m. ET; record date October 27, 2026; notice mailed on or about November 11 — watch quorum proposal (5% to 33⅓%) and share-class consolidation vote

  • Joint special meeting December 16, 2026 at 10:00 a.m. ET; record date October 30, 2026 — watch unitholder approval of iCapital advisory agreement and asset purchase closing conditions

  • Annual Meeting December 3, 2026 at 4:00 p.m. ET; record date October 13, 2026 — watch say-on-pay dissent and Series N-2 warrant approval under Nasdaq 5635(d)

Filing Analyses (10)
SPLASH BEVERAGE GROUP, INC. DEF 14A mixed materiality 7/10

02-11-2026

Splash Beverage Group (now operating as Endovia Health Sciences, Inc.) filed a DEF 14A proxy for a Special Meeting seeking stockholder approval of two NYSE American Section 713/712 proposals: (1) issuance of up to 12,683,908 shares underlying the Series D Convertible Preferred (5,500 shares at $1,000 stated value, $5.5M total, issued July 6, 2026 for the CannEpil® license from Argent Biopharma) and a $576,271 convertible note issued September 18, 2026 to C/M Capital Partners for $510,000 gross proceeds; and (2) issuance of up to 20,000,000 shares under an amended ELOC Agreement with C/M, expanded from $35 million to $100 million (total $135 million including prior amounts). The company warns approval will create 'significant dilution' to current stockholders, however failure to approve would leave it unable to issue shares above the 19.99% Exchange Cap, likely prevent conventional financing, and force repeated special meetings.

  • · Series D conversion price is $1.00 per share with a floor of $0.15; Note conversion price is the lower of $1.75 or $0.01 above closing price on conversion date
  • · Series D conversion may not begin until the later of December 31, 2026, NYSE American approval, and stockholder approval
  • · The Note matures September 18, 2027 and bears no interest absent default
  • · CannEpil® is a proprietary compounded isolated cannabinoid (CBD/THC) liquid formulation for drug-resistant epilepsy and seizure disorders
  • · Company issued 7,173,012 ELOC shares for $2,299,568 gross proceeds between July 1 and October 22, 2026
  • · Abstentions count as votes against the Issuance Proposal; majority of votes cast required
  • · If approval fails, the Company is obligated to call additional stockholder meetings periodically until approval is obtained
  • · Directors and executive officers may be deemed to have an indirect interest in the Authorized Shares Amendment due to anticipated equity awards under the 2025 Plan
  • · Proxy materials will be filed with the SEC within four business days of the Special Meeting date
Digi Power X Inc. DEF 14A neutral materiality 5/10

02-11-2026

Digi Power X Inc. (formerly Digihost Technology) filed a definitive proxy statement for its 2026 Annual General and Special Meeting to be held virtually on December 21, 2026, with a record date of October 27, 2026. Shareholders will vote on electing five director nominees, ratifying auditor Davidson & Company LLP, and four special/ordinary resolutions covering a share-class consolidation (SV and PV shares into one common class), raising the quorum requirement from 5% to 33⅓%, and amending the RSU and Option Plans to fixed maximums of 10,139,668 shares each (~10% of the 101,396,689 shares outstanding as of October 27, 2026) with evergreen provisions. The Board recommends 'FOR ALL' directors and 'FOR' Proposals 2-6; no financial performance figures were disclosed in this filing.

  • · Annual Meeting to be held virtually Monday, December 21, 2026 at 10:00 a.m. Eastern Time
  • · Record date for voting is close of business October 27, 2026
  • · Notice of Internet Availability to be mailed on or about November 11, 2026; proxy materials first available online on or about November 2, 2026
  • · Option Plan to add a fixed term terminating January 18, 2034, consistent with the RSU Plan
  • · Option Plan amendments include revised Schedule B U.S. taxpayer provisions and maximum shares issuable under incentive stock options
  • · RSU Plan amendments add a Schedule A for U.S. taxpayers and remove legacy venture-issuer restrictions to reflect Nasdaq and Cboe Canada listings
  • · Company was formerly named Digihost Technology Inc. (name change March 31, 2021); incorporated in British Columbia; fiscal year end December 31
  • · Annual Report on Form 10-K for fiscal year ended December 31, 2025 prepared under U.S. GAAP is being made available alongside the proxy
C1 Fund Inc. DEF 14A neutral materiality 3/10

02-11-2026

C1 Fund Inc. (CFND) filed a definitive proxy statement for its first annual meeting of stockholders, to be held virtually on December 1, 2026 at Noon Eastern Time, with a record date of October 13, 2026 and 6,096,148 shares of common stock (par value $0.00001) outstanding and entitled to vote. Stockholders will vote on electing Dr. Najamul Hasan Kidwai and Jeffrey H. Singer as Class I directors (terms to 2029) and on ratifying CBIZ CPAs P.C. as independent auditor for fiscal year ending December 31, 2026, with the Board unanimously recommending FOR both proposals. The filing is routine governance with no financial results or performance metrics disclosed, so no period-over-period comparisons are available.

  • · Annual Meeting to be held virtually via live webcast at www.virtualshareholdermeeting.com/CFND2026 on December 1, 2026 at Noon Eastern Time
  • · Record date for voting is close of business October 13, 2026
  • · Proxy materials first released to stockholders on or about November 2, 2026
  • · Proposal 1 (director election) requires a plurality of votes cast; Proposal 2 (auditor ratification) requires a majority of votes cast
  • · Abstentions and broker non-votes have no effect on the outcome of either proposal; broker discretionary voting is allowed on both
  • · Quorum requires holders of a majority of votes entitled to be cast; abstentions and broker non-votes count toward quorum
  • · Proxies must be received on or before Noon on November 30, 2026 for mail voting
  • · Proxies remain valid for up to eleven months from their date unless revoked
  • · Dr. Kidwai has served as a director since October 2024; Mr. Singer has served as a director since October 2024
  • · Dr. Kidwai is founder and former Chairman/Director of Crypto 1 Acquisition Corp, Venture Partner and Investment Committee Member of Frontier Ventures, and Co-Founder/Excomm Member of EQUIAM
  • · Mr. Singer is a director and former Chief Operating Officer of doTERRA International LLC and serves on the board of the Vietnam International Finance Center
  • · Company will bear the cost of soliciting proxies, including preparation, posting and mailing of materials
  • · Company is a Maryland corporation headquartered at 3000 El Camino Real, Palo Alto, CA 94306
Phunware, Inc. DEF 14A neutral materiality 6/10

02-11-2026

Phunware filed a definitive proxy statement for its 2026 Annual Meeting on December 17, 2026, where stockholders will elect one Class II director, ratify CBIZ CPAs P.C. as auditors for FY2026, and hold advisory votes on executive compensation and vote frequency. The meeting is contested: activist Richard Ding of Goldenwise Capital (investment manager of GoldenFuture Capital Investment Ltd.) has nominated an opposing Class II director candidate against the Board's nominee Elliot Han, prompting a proxy fight with dueling WHITE (management) and gold (dissident) proxy cards. The Board unanimously recommends voting FOR its nominee and urges stockholders to discard Goldenwise's gold card; the record date is October 19, 2026.

  • · Annual Meeting to be held virtually on December 17, 2026 at 11:00 a.m. Eastern Time via www.cesonlineservices.com/phun26_vm
  • · Record date for voting is October 19, 2026
  • · Virtual meeting registration deadline is 11:00 a.m. Eastern Time on December 16, 2026
  • · Board nominee Elliot Han would serve a three-year Class II term expiring at the 2029 annual meeting
  • · Proxy solicitor is Alliance Advisors, LLC (Toll-Free 1-888-244-0487; [email protected])
  • · Company headquarters: 1002 West Avenue, Austin, Texas 78701
  • · Because the election is contested, brokers/banks are expected to be unable to vote uninstructed shares on any proposal
  • · A vote to WITHHOLD on the dissident gold card revokes prior WHITE proxy votes
Blaize Holdings, Inc. DEF 14A neutral materiality 6/10

02-11-2026

Blaize Holdings filed a DEF 14A proxy statement for its Annual Meeting on December 1, 2026, asking stockholders to elect all seven current directors to one-year terms and to authorize a reverse stock split at a ratio between 1-for-10 and 1-for-35. The reverse split proposal is a notable signal, typically pursued to restore compliance with exchange minimum bid price requirements, while the board slate is largely a re-election of incumbents with one new nominee, Dr. Kurt Lauk (age 80), who joined the board in August 2026 replacing Dr. Juergen Hambrecht. No financial results, revenue, or period-over-period performance metrics were disclosed in this filing.

  • · Annual Meeting scheduled for December 1, 2026; director terms to expire at the 2027 Annual Meeting
  • · Dr. Kurt Lauk was appointed to the Board effective August 13, 2026, concurrent with the resignation of prior director Dr. Juergen Hambrecht
  • · Dr. Lauk was recommended by the independent directors prior to formation of the Nominating and Corporate Governance Committee, and was appointed to that committee
  • · Director election requires a plurality of votes cast; withheld votes and broker non-votes have no effect
  • · The Reverse Split Proposal permits but does not require the Board to effect a split at a ratio between 1-for-10 and 1-for-35
  • · Six of seven nominees have served since January 2025; only Dr. Lauk is standing for election for the first time
  • · Board unanimously recommends a vote FOR all seven director nominees
INTELLIGENT BIO SOLUTIONS INC. DEF 14A neutral materiality 5/10

02-11-2026

Intelligent Bio Solutions Inc. filed a DEF 14A proxy statement for its virtual Annual Meeting of Stockholders to be held December 3, 2026, at 4:00 p.m. Eastern Time, with a record date of October 13, 2026. Stockholders will vote on eight proposals, including electing four directors, ratifying UHY LLP as independent auditor for fiscal 2027, approving an amended and restated 2019 Long Term Incentive Plan, and approving issuance of up to 2,036,659 shares upon exercise of Series N-2 Warrants issued in a September 2, 2026 private placement under Nasdaq Listing Rule 5635(d). The filing also includes advisory say-on-pay and say-on-frequency votes plus two adjournment authorizations; no financial performance results are disclosed in this excerpt.

  • · Annual Meeting to be held virtually on December 3, 2026 at 4:00 p.m. Eastern Time; no physical meeting location
  • · Record date for voting is October 13, 2026; proxy materials mailed on or about November 2, 2026
  • · Virtual meeting registration deadline is 11:59 p.m. Eastern Time on December 2, 2026
  • · Series N-2 Warrants were issued in a private placement on September 2, 2026
  • · UHY LLP proposed for ratification as independent registered public accounting firm for fiscal year ending June 30, 2027
  • · Company principal executive offices located at 135 West 41st Street, 5th Floor, New York, NY 10036
  • · Annual Report on Form 10-K and Amendment No. 1 on Form 10-K/A cover fiscal year ended June 30, 2026
  • · Proposals 7 and 8 seek authorization to adjourn the meeting to solicit additional proxies for the 2019 Plan Amendment and Nasdaq Proposals respectively
Cantor Fitzgerald Income Trust, Inc. DEF 14A neutral materiality 3/10

02-11-2026

Cantor Fitzgerald Income Trust filed a DEF 14A proxy statement for its annual meeting, asking stockholders to elect five director nominees (Brandon Lutnick, Kyle Lutnick, Arthur F. Backal, John M. Matteson, Dean Palin) and ratify Ernst & Young as independent auditor for fiscal year 2026. The Board recommends FOR both proposals. The filing is routine governance in nature, with no financial performance data disclosed; the only monetary item is an estimated ~$27,000 in proxy solicitation fees payable to Alliance Advisors.

  • · Brandon Lutnick has served as Chairman of the Board since March 2025 and as Chairman of Cantor Fitzgerald, L.P. and CF Group Management, Inc. since February 2025
  • · Kyle Lutnick has served as a director since January 2026; the other three nominees have served since February 2017
  • · Director election requires affirmative vote of a majority of shares entitled to vote present in person or by proxy; a withheld vote or broker non-vote has the same effect as a vote against
  • · Brokers lack discretionary authority on Proposal No. 1 (director election) but have discretionary authority on Proposal No. 2 (auditor ratification)
  • · Ratification of Ernst & Young requires a majority of votes cast; abstentions have no effect
  • · Annual Report to Stockholders covers fiscal year ended December 31, 2025
  • · Company address: 110 East 59th Street, New York, New York 10022
  • · Proxy solicitor hotline: 1-855-206-1315; voting site: https://web.viewproxy.com/CFIT/2026
Planet 13 Holdings Inc. DEFM14A neutral materiality 8/10

02-11-2026

Vireo Growth Inc. will acquire Planet 13 Holdings Inc. through a merger of Vireo's wholly owned subsidiary Supernova Merger Sub Inc. into Planet 13, with each Planet 13 share converting into 0.015383618 of a Vireo subordinate voting share under a merger agreement dated July 26, 2026. The Planet 13 board and an independent special committee unanimously recommend stockholders vote 'FOR' the merger, supported by a fairness opinion from ATB Cormark Capital Markets, though the filing discloses that directors and officers have interests in the merger beyond those of stockholders generally, including accelerated RSU vesting and employment offer letters with Vireo for Larry Scheffler, Robert Groesbeck and Christopher Wren.

  • · Exchange ratio: 0.015383618 of a Vireo Growth subordinate voting share per Planet 13 common share
  • · Merger agreement dated July 26, 2026; Merger Sub incorporated July 25, 2026
  • · Planet 13 restricted stock units vest in full immediately prior to the effective time and are settled in shares converted into merger consideration; no RSUs assumed by Vireo Growth
  • · Planet 13 warrants become exercisable for Vireo subordinate voting shares, with exercise price divided by the exchange ratio
  • · Vireo Growth may require Planet 13 to repay the Revolving Loan Agreement dated June 13, 2024 with Western Alliance Bank and the Related Party Note dated May 10, 2024 between VidaCann, LLC and its former managers; Vireo will pay or assume the debt if Planet 13 cannot
  • · Vireo Growth completed acquisition of The Hawthorne Gardening Company LLC and subsidiaries from The Scotts Miracle-Gro Company on April 8, 2026, and Agribusiness Holdings Limited Partnership (including Bridgewell Agribusiness LLC) on June 5, 2026, creating a new non-cannabis segment
  • · Vireo Growth incorporated November 23, 2004 under the Business Corporations Act (Alberta), existing under the Business Corporations Act (British Columbia); trades on CSE as 'VREO' and OTCQX as 'VREOF'
  • · Planet 13 trades on CSE as 'PLTH' and OTCQX as 'PLNH'; headquartered at 2548 West Desert Inn Road, Suite 100, Las Vegas, Nevada 89109
  • · Dissenters' rights available under Section 92A of the Nevada Revised Statutes
  • · Proxy solicitor: Sodali & Co, 430 Park Avenue, 14th Floor, New York, NY 10022; shareholder toll-free line (800) 662-5200
CPG Vintage Access Fund VII, LLC DEF 14A neutral materiality 5/10

02-11-2026

CPG Vintage Access Fund VII, LLC and six affiliated funds filed a definitive proxy statement for a joint special meeting on December 16, 2026, asking unitholders to approve a new investment advisory agreement appointing iCapital Fund Advisors LLC as adviser, replacing Macquarie Wealth Advisers, LLC. The change follows an October 15, 2026 asset purchase agreement and would reduce the contractual management fee rate after each fund's eighth Final Closing anniversary from 0.30% to 0.25%, while fee rates before that anniversary remain unchanged. The Board unanimously recommends a FOR vote; the transaction is subject to customary closing conditions and majority unitholder approval under the 1940 Act.

  • · Record date for voting: October 30, 2026; each full unit entitles holder to one vote
  • · Special Meeting held virtually at www.virtualshareholdermeeting.com/macquarie on December 16, 2026 at 10:00 A.M. Eastern time
  • · Macquarie entered asset purchase agreement with iCapital Fund Advisors on October 15, 2026
  • · Board approved New Advisory Agreement at October 14, 2026 Board Meeting, following meetings on September 29 and October 7, 2026
  • · Macquarie to resign as adviser effective on or about January 29, 2027; New Advisory Agreement effective on or about January 30, 2027
  • · Proxy materials to be mailed beginning on or about November 4, 2026
  • · Proposal will not change any Fund's investment objective, strategy, risks or restrictions
  • · Each Fund's unitholders vote separately on the Proposal; majority unitholder approval required under the 1940 Act
  • · Proxy materials available at www.proxyvote.com; Broadridge hotline 844-986-0822 (US) / 303-562-9302 (International)
CURIS INC DEF 14A neutral materiality 6/10

02-11-2026

Curis, Inc. filed a definitive proxy statement for a virtual Special Meeting of stockholders on November 18, 2026, seeking approval of amendments to its Restated Certificate of Incorporation to effect a reverse stock split at a ratio between 1-for-5 and 1-for-12, with the exact ratio to be set by the Board. A second proposal would allow adjournment of the meeting if insufficient votes are obtained for Proposal 1. Only 6,679,229 shares of common stock were outstanding as of the October 26, 2026 record date, a notably small share count that underscores the likely rationale for the reverse split.

  • · Reverse stock split ratio range: any whole number between 1-for-5 and 1-for-12, at Board discretion, subject to Board authority to abandon the amendments
  • · Special Meeting to be held virtually on November 18, 2026 at 11:00 a.m. Eastern Time at www.virtualshareholdermeeting.com/CRIS2026SM3
  • · Record date: close of business October 26, 2026; proxy materials mailed on or about November 2, 2026
  • · Proxy submission via Internet or telephone must be completed by 11:59 p.m. Eastern Time on November 17, 2026
  • · Online check-in for the meeting begins at 10:45 a.m. Eastern Time on November 18, 2026
  • · No appraisal rights are available to stockholders in connection with the reverse stock split
  • · Company headquarters: 128 Spring Street, Building C – Suite 500, Lexington, Massachusetts 02421
  • · No filing fee required for this proxy statement

Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 10 filings

$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.

More from: US Executive Compensation Proxy SEC Filings

🇺🇸 More from United States

View all →